Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Domestic Revenue	144.43B	135.18B	Log In	Log In	Log In	Upgrade
Europe Revenue	3.06T	2.96T	Log In	Log In	Log In	Upgrade
USA Revenue	1.55T	1.17T	Log In	Log In	Log In	Upgrade
Other Geographic Revenue	278.82B	274.75B	Log In	Log In	Log In	Upgrade

Revenue Breakdown

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Contract Development and Manufacturing Organization (CDMO) Revenue	3.01T	Log In	Log In	Log In	Upgrade
Biopharmaceutical Development and Commercialization Revenue	1.54T	Log In	Log In	Log In	Upgrade

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Product Revenue	4.79T	4.17T	Log In	Log In	Log In	Upgrade
Other Revenue	238.67B	382.25B	Log In	Log In	Log In	Upgrade

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Contract Development and Manufacturing Organization (CDMO) Operating Profit	1.12T	Log In	Log In	Log In	Upgrade
Biopharmaceutical Development and Commercialization Operating Profit	200.69B	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.